Clinical Trial Update: A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1) [Phase 2]

View source ↗

Summary

A randomized open-label Phase 2 study evaluating KLH-2109 in endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• KLH-2109

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED